Skip to content

SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep in Total Shoulder Arthroplasty

SURGX Antimicrobial Gel Versus Povidone-iodine Skin Incision Prep for the Prevention of Bacterial Seeding in Total Shoulder Arthroplasty

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05919888
Enrollment
60
Registered
2023-06-26
Start date
2023-06-26
Completion date
2023-11-14
Last updated
2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutibacterium Acnes, Prosthetic-joint Infection, Surgery, Surgical Site Infection

Keywords

Antimicrobial wound gel, SURGX, Betadine, Dermal layer, Skin preparation

Brief summary

Comparing the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus antimicrobial wound gel versus betadine applied to the skin layer after the skin incision has been made. Reducing the bacteria present in the deep tissues at the end of the surgery may prevent infections from developing in the future.

Detailed description

Cutibacterium acnes (C. acnes) prosthetic joint infection is a devastating and somewhat unique complication to shoulder arthroplasty. It is a very slow-growing, aerotolerant anaerobic, non-spore forming, gram-positive rod-shaped bacteria that takes up to 2-3 weeks to grow in a lab setting. There have been several studies assessing various agents in the fight to prevent C. acnes prosthetic joint infection. These agents include standard peri-operative measures typically taken when performing shoulder replacement surgery - pre-operative prophylactic antibiotics, pre-operative skin cleanse/wash, topical adjuvants (povidone-iodine, chlorhexidine, etc.), and intra-operative antibiotic powders. The overall infection rate of shoulder arthroplasty has been cited to be between 0.9-2.9%, with C. acnes being the most common bacterium in shoulder arthroplasty periprosthetic infections. Morbidity and cost associated with shoulder prosthetic joint infection is extremely high, requiring multiple surgeries and months of treatment to overcome the infection. One of the main issues with C. acnes is its preferred location within the body, residing within the sebaceous glands of the hair follicles, deep to the epidermis where many preoperative topical preparations to cleanse the skin prior to surgery have little affect. These glands are commonly found around the shoulder and upper back, and lead to acne. C. acnes, along with other common prosthetic joint infection bacteria, quickly create a biofilm which is impenetrable to most antibiotic agents, further stressing the importance of prevention. Recently there have been studies analyzing the effects of Benzoyl Peroxide (BPO) on C. acnes as it relates to shoulder arthroplasty in an attempt to reduce this bacterial burden prior to surgery. There have been promising results with multi-day preparation skin cleansing with benzoyl peroxide. However, there are no studies looking at intra-operative skin incision preparations targeting the region of skin where the C. acnes bacteria resides. In vitro studies show SURGX antimicrobial gel (Next Science, Jacksonville, FL) results in a marked reduction of C. acnes in addition to other common bacteria affecting prosthetic joints. This gel uses citric acid to chelate the metallic bonds of biofilm. The bacteria are then destroyed by a combination of a high osmolarity environment coupled with a surfactant. The first purpose of the study is to evaluate if a dermal layer preparation will reduce positive cultures of C. acnes after primary shoulder arthroplasty. There will be a control group consisting of no skin preparation. There will be two additional comparative groups. The second purpose of this study is to compare the use of standard povidone-iodine swab versus SURGX antimicrobial gel as an application into the dermal layer after the skin incision has been made with a skin knife to see if there is a reduction in bacterial burden in the superficial and deep tissues at the end of a primary shoulder arthroplasty. Superficial and deep cultures will be obtained at the conclusion of the shoulder replacement surgery. These cultures will be held in the lab for 2 weeks to identify if bacteria is present. The study team's hypothesis is that the SURGX antimicrobial gel will provide a greater reduction in bacterial burden compared to povidone-iodine within the deep tissues after primary shoulder arthroplasty.

Interventions

DRUGPovidone-Iodine

Applied to skin incision.

DEVICESURGX Wound Gel

Applied to skin incision.

Sponsors

Next Science LLC
CollaboratorUNKNOWN
St. Louis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Intervention model description

This is a prospective clinical trial in which patients will be assigned a study arm in sequential fashion.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Patient is planned to undergo elective primary anatomic or reverse shoulder arthroplasty.

Exclusion criteria

* Patient is undergoing revision shoulder replacement surgery. * Patient has a known allergy to iodine, benzalkonium chloride, or polythylene glycol.

Design outcomes

Primary

MeasureTime frameDescription
Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no PrepDay 14Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of bacteria. The number of patients with at least one positive culture were compared among the three study arms.

Secondary

MeasureTime frameDescription
Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine PrepDay 14Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of baceria. The number of patients with at least one positive culture were compared among the SURGX and povidone-iodine groups.

Countries

United States

Participant flow

Recruitment details

Participants were recruited by physicians at 1 academic medical center between June 2023 and November 2023.

Pre-assignment details

60 participants were enrolled, and all 60 met inclusion criteria and were randomized to a study arm.

Participants by arm

ArmCount
No Skin Incision Preparation
The control group will receive no dermal layer skin preparation. At the time of the surgery, after the skin incision has been made with a skin knife, the dermal layer will not be prepped with an agent.
20
Povidone-iodine
At the time of the surgery, after the skin incision has been made, the dermal layer will be prepped with povidone-iodine. Drug: povidone-iodine Dose: swabstick Administration: swab the incision Frequency: once Povidone-Iodine: Applied to skin incision.
20
SURGX Wound Gel
At the time of the surgery, after the skin incision has been made, the dermal layer will be prepped with SURGX Wound Gel. SURGX wound gel is a topical antiseptic gel agent to be used on surgical incisions to prevent bacterial infection. SURGX Wound Gel: Applied to skin incision.
20
Total60

Baseline characteristics

CharacteristicNo Skin Incision PreparationPovidone-iodineSURGX Wound GelTotal
Age, Continuous69.35 years
STANDARD_DEVIATION 8.443
68.50 years
STANDARD_DEVIATION 10.405
68.75 years
STANDARD_DEVIATION 7.107
68.87 years
STANDARD_DEVIATION 8.615
BMI29.1880 kg/m2
STANDARD_DEVIATION 7.22953
32.5010 kg/m2
STANDARD_DEVIATION 5.58499
30.7310 kg/m2
STANDARD_DEVIATION 6.53229
30.8067 kg/m2
STANDARD_DEVIATION 6.51775
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
18 Participants20 Participants18 Participants56 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants2 Participants4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants1 Participants3 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants1 Participants1 Participants4 Participants
Race (NIH/OMB)
White
16 Participants18 Participants18 Participants52 Participants
Sex: Female, Male
Female
10 Participants14 Participants15 Participants39 Participants
Sex: Female, Male
Male
10 Participants6 Participants5 Participants21 Participants
Type of Shoulder Arthroplasty
Anatomic TSA
3 Participants1 Participants3 Participants7 Participants
Type of Shoulder Arthroplasty
Reverse TSA
17 Participants19 Participants17 Participants53 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 201 / 200 / 20
other
Total, other adverse events
0 / 200 / 200 / 20
serious
Total, serious adverse events
2 / 203 / 202 / 20

Outcome results

Primary

Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep

Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of bacteria. The number of patients with at least one positive culture were compared among the three study arms.

Time frame: Day 14

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
No Skin Incision PreparationPresence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep11 Participants
Povidone-iodinePresence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep9 Participants
SURGX Wound GelPresence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep6 Participants
p-value: 0.275Chi-squared
Primary

Presence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep

Each participant had 5 total culture swabs at end of surgical case from deep (2), superficial (2), and implant (1) locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of bacteria. The number of positive cultures after 2 weeks were compared among the control group and SURGX group.

Time frame: Day 14

Population: Each participant had 5 total culture swabs at end of shoulder surgery from deep (2), superficial (2), and implant (1) locations.

ArmMeasureValue (NUMBER)
No Skin Incision PreparationPresence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep29 # of positive cultures
Povidone-iodinePresence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep24 # of positive cultures
SURGX Wound GelPresence of Bacteria Within Shoulder Culture Using Incisional Prep vs. no Prep13 # of positive cultures
p-value: 0.0056Chi-squared
Secondary

Presence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep

Each participant had culture swabs at end of surgical case from deep, superficial, and implant locations. Cultures were held in the lab for 2 weeks to evaluate for the presence of baceria. The number of patients with at least one positive culture were compared among the SURGX and povidone-iodine groups.

Time frame: Day 14

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
No Skin Incision PreparationPresence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep11 Participants
Povidone-iodinePresence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep9 Participants
SURGX Wound GelPresence of Bacteria Within Shoulder Culture Using SURGX Wound Gel Prep vs. Povidone-iodine Prep6 Participants
p-value: 0.286Chi-squared

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026